Phase 2, Open-Label Study for Safety, Microbiology and PK of Single or Multiple Oral C16G2 Gel Doses
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
Part A: Open-label, multiple arm, safety, microbiology and pharmacokinetic (PK) study in
healthy adult male and female subjects 18-75 years of age. All subjects will be assessed for
safety and microbiology parameters. A subset of subjects will be assessed for pharmacokinetic
parameters. No longer enrolling study subjects in Part A.
Part B: Open-label, multiple arm, safety and microbiology study in healthy adult male and
female subjects 18-75 years of age. All subjects will be assessed for safety,
pharmacokinetic, and microbiology parameters.